Analyst Ratings for Danaher (DHR)
DHR Rating Summary
DHR Price Target Summary
- Highest: $300.00 (Leerink Partners)
- Lowest: $123.00 (Wells Fargo)
- Average: $263.16
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$263.16 (+5.1%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
Avg. $ Target:
$263.16 (+5.1%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2024 | Nephron | Jack Meehan | Upgrade | Buy (Hold) |
275.00 (N/A) |
233.93 (250.41) |
7.04% | Details |
| 1/24/2024 | Barclays » Updated 4/24/2024 |
Luke Sergott | Downgrade | Equalweight (Overweight) |
270.00 (260.00) |
232.10 (250.41) |
7.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
